In another eye - opening study published in The Journal of Nutritional Biochemistry, researchers discovered that ALA can actually prevent
non-alcoholic steatosis brought on by excessive intake of fats.
Not exact matches
Non-alcoholic fatty liver disease (NAFLD) is defined medically as macrovesicular
steatosis, or abnormal retention of lipids (fats) sufficient and large enough to distort or replace the nuclei of liver cells among those who consume less than 20 grams -LRB-.7 ounces) of alcohol per day.
Hepatic
steatosis is defined as the excessive accumulation of fat in the liver and it is the key characteristic of
non-alcoholic fatty liver disease (NAFLD).
Hepatic
steatosis is defined as the excessive accumulation of fat in the liver and it is the key characteristic of
non-alcoholic fatty liver disease.
NAFLD encompasses a spectrum of disease states, from
steatosis (fatty liver) to
non-alcoholic steatohepatitis (also called NASH;
steatosis with inflammatory changes) followed by progression to fibrosis and cirrhosis and hepatocellular carcinoma (27).
Nuts show therapeutic potential in treating people with
non-alcoholic fatty liver disease through improvements to lipid profile, hepatic
steatosis and inflammation.